Psilocybin & Neuroplasticity: Can Magic Mushrooms “Rewire” the Brain?

A lot of what we know about psilocybin’s impact on neuroplasticity comes from animal studies and early-stage clinical trials. Get into the science of P. Cubensis’s main psychoactive compound here.

Can a mushroom compound actually rewire your brain? 

The emerging science suggests the answer is yes — and the potential implications are profound.

Indigenous cultures have used psilocybin mushrooms for thousands of years, but scientific research into their effects on the brain has only emerged in recent decades.

We’re currently in the midst of a psychedelic research renaissance. Halted in 1970 due to regulatory bans, scientific research on psilocybin has now restarted.

One of the most promising areas of research is its effect on neuroplasticity.

Neuroplasticity Explained 

Neuroplasticity, simply put, is the brain’s remarkable ability to rewire itself by forming and modifying neural connections.

It was once thought to be limited to early development, but now we know it’s lifelong and essential for learning, memory, and recovery from injury.

There are four basic mechanisms underlying neuroplasticity:

1. Synaptic plasticity –  strengthening or weakening of connections between neurons

2. Structural plasticity – physical changes in brain structure, such as new synapse formation, dendritic growth, or pruning

3. Neurogenesis – the development of new neurons, primarily in the hippocampus

4. Functional reorganization – allocating functions to other parts of the brain

Neuroplasticity is not only necessary for learning and healthy aging, but also for mental health. Neuroplasticity can be either adaptive (allowing you to learn a new language, recover from stroke, or improve memory) or maladaptive (cementing chronic pain, addiction, or anxiety disorders).

Essentially, the same neural mechanisms that enable you to learn “hello” in Portuguese can also reinforce negative habits like compulsive phone scrolling or anxiety shopping.

The Mechanism: How Psilocybin Promotes Neuroplasticity 

Psilocybin shares a chemical resemblance to serotonin and binds primarily to the 5-HT2A serotonin receptor.

When ingested, it is converted into psilocin and primarily acts on the 5-HT2A serotonin receptor, triggering a series of mechanisms. The activation allows the release of glutamate and the entry of calcium, strengthening synaptic plasticity through the heightened density of AMPA receptors on the neurons. (Ly et al., 2021 1; Frontiers 2025 2). More simply put, psilocybin makes neurons more receptive to signals from neighbors.

Psilocybin also increases levels of the protein brain-derived neurotrophic factor (BDNF), a protein that acts as fertilizer for the brain. This protein helps brain cells in growing new arms and in forming new connections with other brain cells. The exciting part is that these effects don’t just take place during a psilocybin experience, but can last long after the experience, providing an extended window of enhanced neuroplasticity.

This illustrates how psilocybin can help rewire maladaptive neural circuits and facilitate mental health recovery. 3

What the Research Shows

A lot of what we know about psilocybin’s impact on neuroplasticity comes from animal studies and early-stage clinical trials.

Animal Studies: Structural Brain Changes

Tests on mice show that even a single dose increases the levels of plasticity-associated genes like BDNF, c-Fos, and mTOR. More importantly, it increases the density of dendritic spines (the tiny protrusions on neurons where connections are formed) in the hippocampus and prefrontal cortex, regions critical for memory and decision-making. These changes persist for up to a week after administration. (Frontiers in Systems Neuroscience, 2025 4; PMC, 2024 5; PubMed, 2023 6)

Other studies show that mice given psilocybin accelerate the removal or erasure of conditioned fear responses, meaning that they actually “unlearn” fear associations more quickly. This lines up with the brain growing new neurons and forming fresh connections between them. Basically, psilocybin might help the brain break free from old, unhelpful patterns.

Human Neuroimaging: Network-Level Changes

If we look at human brain scans, we find something remarkable. Psilocybin seems to boost communication between areas that handle movement and sensation, and simultaneously appears to soothe the Default Mode Network — the area of our brain that handles that internal narrator, the voice that we hear “in our head” and keeps us in touch with a sense of “me” or “self.”

A 2024 report by Siegel and colleagues (Nature, 2024 7) found that psilocybin dramatically shifts how the DMN communicates with the rest of the brain. The reorganization appears to be what is behind profound experiences people have on psilocybin—the feeling of ego collapse, of seeing the world in a completely different way. The really striking thing is that those differences in the brain don’t appear to vanish once the psilocybin experience has ended. They persist for weeks, which might explain why people report lasting improvements in mood and mental flexibility long after the experience.

What all this science shows is really remarkable: psilocybin’s not just transiently altering brain chemistry like most psychiatric medication. It’s re-wiring the brain at multiple scales, from individual molecules to large networks. The effects come on quickly, but also linger. That’s what makes it so promising for mental health treatment.

Emerging Trends & Future Directions 

Psilocybin research is also rapidly growing, with increasingly more scientists investigating its therapeutic potential for conditions such as PTSD, obsessive-compulsive disorder (OCD), and substance use disorders. Read the latest science in our article on psilocybin and depression.

Johns Hopkins University’s landmark 2016 study demonstrated that one psilocybin high-dose session led to big and long-lasting decreases in depression and anxiety in cancer patients, with the effects lasting for six months or longer (Johns Hopkins University, 2016 8). 

Emerging therapeutic models, such as group psychedelic-assisted therapy for veterans, healthcare workers, and first responders, are exploring how psilocybin can best serve different individuals and communities.

Researchers are also examining how psilocybin therapy can help people not only feel better but also reconnect with daily life, relationships, and purpose. As the regulatory landscape keeps shifting — with the FDA granting “breakthrough therapy” designation — the focus is on responsible use, preparation, dosing, and integration support.

If you’re curious about psychedelic integration, read our article Psychedelic Integration and Psilocybin.

Key questions remain: What are workable doses? How do individual differences impact response? What are the precise mechanisms through which psilocybin brings about lasting change?

Answering these will be important for maximizing benefits of psilocybin and minimizing risks.

Rewiring the Brain with Psilocybin

So back to our original question… can a mushroom molecule rewire our brain? The answer, ever more so, is yes.

Psilocybin’s ability to increase neuroplasticity has tremendous potential for transforming mental health treatment and bolstering brain resiliency.

But it’s also crucial to approach this compound with humility and care. Psilocybin is not a magic pill, and its effects are context-dependent, prep-dependent, and integration-dependent. As research goes forward, the emphasis must remain on safety, education, and sensitivity to indigenous cultures that have utilized these mushrooms for thousands of years.

Sources

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC7830000/
2. https://doi.org/10.1016/j.brainres.2025.149643
3. https://pnwspore.com/psilocybin-and-depression/
4. https://www.frontiersin.org/journals/systems-neuroscience/articles/10.3389/fnsys.2025.1585367/full
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC11853016/
6. https://pubmed.ncbi.nlm.nih.gov/37000971/
7. https://www.nature.com/articles/s41586-024-07624-5
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC5289681/